Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Diego Franco
 -- 1541 2023-10-11 11:01:59 |
2 Reference format revised.
Lindsay Dong
 Meta information modification 1541 2023-10-13 02:54:18 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Castillo-Casas, J.M.; Caño-Carrillo, S.; Sánchez-Fernández, C.; Franco, D.; Lozano-Velasco, E. Experimental Injury Models of Cardiac Regeneration. Encyclopedia. Available online: https://encyclopedia.pub/entry/50108 (accessed on 05 September 2024).
Castillo-Casas JM, Caño-Carrillo S, Sánchez-Fernández C, Franco D, Lozano-Velasco E. Experimental Injury Models of Cardiac Regeneration. Encyclopedia. Available at: https://encyclopedia.pub/entry/50108. Accessed September 05, 2024.
Castillo-Casas, Juan Manuel, Sheila Caño-Carrillo, Cristina Sánchez-Fernández, Diego Franco, Estefanía Lozano-Velasco. "Experimental Injury Models of Cardiac Regeneration" Encyclopedia, https://encyclopedia.pub/entry/50108 (accessed September 05, 2024).
Castillo-Casas, J.M., Caño-Carrillo, S., Sánchez-Fernández, C., Franco, D., & Lozano-Velasco, E. (2023, October 11). Experimental Injury Models of Cardiac Regeneration. In Encyclopedia. https://encyclopedia.pub/entry/50108
Castillo-Casas, Juan Manuel, et al. "Experimental Injury Models of Cardiac Regeneration." Encyclopedia. Web. 11 October, 2023.
Experimental Injury Models of Cardiac Regeneration
Edit
This entry is adapted from the peer-reviewed paper 10.3390/jcdd10080325

Cardiac regeneration is an ancestral trait in vertebrates, a general capacity that seems to be inversely correlated with evolutionary complexity across the animal kingdom. To better understand the biology of MI, as well as to develop different therapeutic strategies, in vitro, ex vivo and in vivo models have been developed. 

cardiac disease myocardial infarction cell cycle heart regeneration

1. Introduction

Cardiovascular diseases are the leading cause of death worldwide, and, among all of them, ischemic heart disease affects around 126 million individuals [1][2]. Myocardial Infarction (MI) is driven by death and loss of cardiomyocytes (CMs) at the site of ischemic injury [3]. The lack of oxygen supply leads to adverse remodeling in the affected myocardium leading to cell death. Moreover, the restoration of the oxygenated blood flow during the reperfusion process can paradoxically accelerate an additional myocardial injury due to a high production of reactive oxygen species (ROS), promoting oxidative stress and thus an extra wave of CM cell deaths [4][5][6][7]. Necrotic CMs are replaced by myofibroblasts forming a fibrotic tissue scar that drastically diminishes CMs’ contractile potential affecting the functional rate of the heart and eventually leading to heart failure (HF) [8][9][10][11]. Mammalian adult hearts do not have the ability to survive a substantial loss of CMs, making cardiac regeneration one of the major avenues in human cardiovascular research [12][13].

2. Experimental Models of Cardiac Regeneration

Cardiac regeneration is an ancestral trait in vertebrates, a general capacity that seems to be inversely correlated with evolutionary complexity across the animal kingdom [14][15]. For example, the human heart has a very limited capacity for cardiac regeneration in contrast to fish and amphibian organisms [16][17]. Some years ago, Field’s lab evidenced that a low percentage of mouse ventricular CMs have proliferative capacity in normal conditions in mice, becoming higher after injury [18]. In the same line, it has been demonstrated that 1% of human CMs are renewed each year [12]. In a cardiac injured scenario, this low percentage of CM renewal is not enough to repair the damaged myocardium. Some laboratories, within the cardiovascular field, are focusing their efforts on increasing the proliferative ability of CMs in order to enhance the regenerative capacity of mammalian hearts. To better understand the biology of MI, as well as to develop different therapeutic strategies, in vitro, ex vivo and in vivo models have been developed.
The first approach is the in vitro cardiac model which implies primary cultures and/or cell lines. Concretely, CMs can be obtained from animal or human hearts or by the differentiation process from stem cells. In general terms, CMs from primary culture have some limitations for the study of cardiac physiology, such as low proliferative capacity and the absence of spontaneous beat, among others [19][20][21][22][23]. As an alternative, differentiated CMs derived from pluripotent cells, mesenchymal stem cells (MSCs), embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs), are essential for the development of MI models [24][25][26][27][28].
On the other hand, ex vivo models involve keeping the heart outside of the body in a normal or retrograde perfusion system. This kind of model offers the opportunity to generate ischemic and reperfusion situations to analyze the effects of MI [29][30][31]. The main advantage of this model is that the infarct size can be measured and left ventricular function can be easily assessed [32][33][34].
Last but not least are the in vivo models: they represent the most used model to test MI effects as well as for drug and safety studies. This model offers the opportunity of analyzing the vast majority of physiological changes generated in response to MI, i.e., inflammatory processes and scar formation as well as the possibility of identifying blood biomarkers [32]. In the in vivo scenario, researchers have the possibility of employing different strategies that enable the study of different molecular mechanisms, but need to take into consideration the variability associated to injury degree (mild, moderate and severe), as well as surgical and postoperative mortality [32]. 

3. Injury Models to Study Cardiac Healing

Nowadays, the most important goal of cardiac researchers is to decipher the mechanisms that control heart regeneration in distinct animal models with the intention of stimulating cardiac repair in adult mammals. To perform this challenging goal, several different methods are applied to simulate a cardiac injury that is similar to the damage generated by MI.
The cryoinjury technique is based on the exposition of the cardiac apical left ventricle area to a liquid nitrogen cooled cryoprobe [35] (Figure 1A). By using this technique, it is noteworthy that, depending on the damage severity, the cardiac regenerative response can be different. Transmural injury is the highest degree of damage with this technique, where the full wall diameter of the ventricle is affected, whereas non-transmural injury, where the cryoprobe does not penetrate the wall ventricle, inflicts mild damage [36].
Jcdd 10 00325 g001 550
Figure 1. Graphical summary of (A) injury models of myocardial infarction and (B) interspecies comparisons of heart regenerative and non-regenerative capacity.
Another injury model is apical resection; it consists of the removal of a small piece of tissue, no more than 15%, from the apical left ventricle wall after heart exposure [37][38] (Figure 1A). Immediately after apical resection there is an inflammatory process which ends with the generation of a blood clot that seals the resected area, thus starting the regenerative process [39]. Although apical resection provides an easy model of CM loss, the main limitation of this procedure is restricted to P1-P7 mice because in older animals the mortality rate is much more elevated [37].

4. Heart Regeneration after Injury in Different Animal Models

4.1. Invertebrate Models

The ability to replace lost body parts or tissues is a phenomenon that is peculiar to a few organisms from different clades in the animal kingdom. Within the invertebrate group, hydras and planarians stand out, due to their ability to completely regenerate their bodies after an amputation [40]. These models allow us a first approach to the morphological and cellular dynamic changes involved in regeneration [41]. Hydras and planarians are two in vivo models with simple cellular organization that make them useful model systems to better study and understand stem cell behavior and regenerative processes in higher evolutionary models.

4.2. Vertebrate Models

Fish models

Several fish species have shown the ability to repair an injured heart through the induction of CM proliferation (Figure 1B). For example, zebrafish (Danio rerio) have the ability of total heart regeneration 60 days after ~20% apical resection of the ventricle, by activating the proliferation rate of the CMs present in the surrounding injured area [16][42]. Something similar happens when ~25% of the zebrafish’s ventricle is damaged by using a cryoprobe. In this type of heart injury model, although the regeneration process is much slower, the heart achieves restoration in approximately ~180 days [43][44][45]. Finally, Poss’ lab developed a tamoxifen-inducible genetic ablation model that allowed the promotion of 60% of CM cell death. In this case, 30-day post tamoxifen induction they observed a complete re-muscularized ventricle [46]. Moreover, a few years ago, Gonzalez-Rosas et al. (2018) [47] reported that most of the zebrafish’s CMs contain only two sets of homologous chromosomes. These diploid CMs have the ability to proliferate, inducing heart regeneration [48]. Finally, considering that zebrafish resides in a hypoxic environment, this restrictive O2 condition enables CM dedifferentiation and proliferation leading to heart regeneration [42].

Amphibian models

Similar to fishes, some urodele amphibians have the ability to regenerate several tissues and organs [49][50] (Figure 1B). For example, axolotls (Ambystoma mexicanus), which are neotenic aquatic urodele amphibians, are capable of regenerating the heart after injury, resection and cryo-injury, but only in the larval phase [49][50][51]. However, when axolotls undergo metamorphosis and get into the adulthood stage, regeneration, in general terms, is reduced and some morphological defects are still observed [52]. This animal group loses its overall regenerative capacity as it undergoes metamorphosis, concomitantly with maturation of the immune system, which is comparable to that of mammals [53][54]. There are no studies about heart regeneration in adult axolotls, however it is important to highlight that thyroid hormone, which is necessary in this species to undergo metamorphosis into a land-dwelling adult, impairs heart regeneration in zebrafish [51][55]. In these terms, newts as Notophthalmus viridescens, bear heart regeneration capacity dependent on the type of injury [17][56][57][58][59] (Figure 1B). 

Chicken models
Avian cardiac regenerative capacity has not been thoroughly investigated. Burn lesions in chicken (Gallus gallus) myocardium resolve as regeneration in 3- and 5-day old chick embryos [60][61]. Furthermore, a study carried out by Novikov and Khloponin in 1984 demonstrated that chickens have the ability to repair cardiac damage at early embryonic stages. This process takes about 7 to 10 days after injury with the intervention of all three layers of the embryonic heart, i.e., epicardium, endocardium and myocardium [61].
Mammal models
Lastly, it is widely known that the mammalian heart does not have the ability to regenerate after an injury process (Figure 1B). However, more than a decade ago, Porrello et al. (2011), revealed that heart regeneration was achieved in mice (Mus musculus) when apical resection was performed at postnatal day 1 (P1). This regenerative event lasted a period of 21 days and was carried out by proliferation of the existing CMs in the surrounding injured area [62][63]. Similarly, a full cardiac recovery is observed in mice after ligation of the left anterior descending (LAD) coronary artery in P1 [64]. On the other hand, the heart behavior after ventricle cryoinjury is different depending on severity; i.e., non-transmural cryoinjury in P1 mice undergoes healing, while P1 mice with transmural cryoinjury do not attain complete regeneration [36][65][66].

References

  1. Khan, M.A.; Hashim, M.J.; Mustafa, H.; Baniyas, M.Y.; Al Suwaidi, S.K.B.M.; AlKatheeri, R.; Alblooshi, F.M.K.; Almatrooshi, M.E.A.H.; Alzaabi, M.E.H.; Al Darmaki, R.S.; et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 23 July 2020. Available online: https://www.cureus.com/articles/36728-global-epidemiology-of-ischemic-heart-disease-results-from-the-global-burden-of-disease-study (accessed on 20 July 2023).
  2. Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Barengo, N.C.; Beaton, A.; Benjamin, E.J.; Benziger, C.P.; et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update from the GBD 2019 Study. J. Am. Coll. Cardiol. 2020, 76, 2982–3021.
  3. Thygesen, K.; Alpert, J.S.; Jaffe, A.S.; Chaitman, B.R.; Bax, J.J.; Morrow, D.A.; White, H.D.; The Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J. Am. Coll. Cardiol. 2018, 72, 2231–2264.
  4. Kalogeris, T.; Baines, C.P.; Krenz, M.; Korthuis, R.J. Cell Biology of Ischemia/Reperfusion Injury. In International Review of Cell and Molecular Biology, 1st ed.; Elsevier Inc.: Amsterdam, The Netherlands, 2012; Volume 298, 229p.
  5. Hausenloy, D.J.; Barrabes, J.A.; Bøtker, H.E.; Davidson, S.M.; Di Lisa, F.; Downey, J.; Engstrom, T.; Ferdinandy, P.; Carbrera-Fuentes, H.A.; Heusch, G.; et al. Ischaemic conditioning and targeting reperfusion injury: A 30 year voyage of discovery. Basic Res. Cardiol. 2016, 111, 70.
  6. Granger, D.N.; Kvietys, P.R. Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol. 2015, 6, 524–551.
  7. Neri, M.; Riezzo, I.; Pascale, N.; Pomara, C.; Turillazzi, E. Ischemia/reperfusion injury following acute myocardial infarction: A critical issue for clinicians and forensic pathologists. Mediat. Inflamm. 2017, 2017, 7018393.
  8. Jennings, R.B.; Sommers, H.M.; Smyth, G.A.; Flack, H.A.; Linn, H. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch. Pathol. 1960, 70, 68–78.
  9. Kathiresan, S.; Srivastava, D. Genetics of human cardiovascular disease. Cell 2012, 148, 1242–1257.
  10. Lu, B.; Yu, H.; Zwartbol, M.; Ruifrok, W.P.; van Gilst, W.H.; de Boer, R.A.; Silljé, H.H.W. Identification of hypertrophy- and heart failure-associated genes by combining in vitro and in vivo models. Physiol. Genom. 2012, 44, 443–454.
  11. Sarkar, K.; Cai, Z.; Gupta, R.; Parajuli, N.; Fox-Talbot, K.; Darshan, M.S.; Gonzalez, F.J.; Semenza, G.L. Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning. Proc. Natl. Acad. Sci. USA 2012, 109, 10504–10509.
  12. Bergmann, O.; Bhardwaj, R.D.; Bernard, S.; Zdunek, S.; Barnabé-Heider, F.; Walsh, S.; Zupicich, J.; Alkass, K.; Buchholz, B.A.; Druid, H.; et al. Evidence for cardiomyocyte renewal in humans. Natl. Inst. Health 2009, 324, 98–102.
  13. Senyo, S.E.; Steinhauser, M.L.; Pizzimenti, C.L.; Yang, V.K.; Cai, L.; Wang, M.; Wu, T.-D.; Guerquin-Kern, J.-L.; Lechene, C.P.; Lee, R.T. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013, 493, 433–436.
  14. Yun, M.H. Changes in Regenerative Capacity through Lifespan. Int. J. Mol. Sci. 2015, 16, 25392–25432.
  15. Vivien, C.J.; Hudson, J.E.; Porrello, E.R. Evolution, comparative biology and ontogeny of vertebrate heart regeneration. NPJ Regen. Med. 2016, 1, 16012.
  16. Poss, K.D.; Wilson, L.G.; Keating, M.T. Heart regeneration in zebrafish. Science 2002, 298, 2188–2190.
  17. Becker, R.O.; Chapin, S.; Sherry, R. Regeneration of the ventricular myocardium in amphibians. Nature 1974, 248, 145–147.
  18. Soonpaa, M.H.; Field, L.J. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am. J. Physiol. Circ. Physiol. 1997, 272, H220–H226.
  19. Yadav, V.; Chong, N.; Ellis, B.; Ren, X.; Senapati, S.; Chang, H.C.; Zorlutuna, P. Constant-potential environment for activating and synchronizing cardiomyocyte colonies with on-chip ion-depleting perm-selective membranes. Lab A Chip 2020, 20, 4273–4284.
  20. Ellis, B.W.; Dmitry, O.; Traktuev; Merfeld-Clauss, S.; Can, U.I.; Wang, M.; Bergeron, R.; Zorlutuna, P.; March, K.L. Adipose Stem Cell Secretome Markedly Improves Rodent Heart and hiPSC-derived Cardiomyocyte Recovery from Cardioplegic Transport Solution Exposure. Stem Cells 2021, 39, 170–182.
  21. He, L.; Zhou, B. Cardiomyocyte proliferation: Remove brakes and push accelerators. Cell Res. 2017, 27, 959–960.
  22. Zhao, M.T.; Ye, S.; Su, J.; Garg, V. Cardiomyocyte Proliferation and Maturation: Two Sides of the Same Coin for Heart Regeneration. Front. Cell Dev. Biol. 2020, 8, 594226.
  23. Peter, A.K.; Bjerke, M.A.; Leinwand, L.A. Biology of the cardiac myocyte in heart disease. Mol. Biol. Cell 2016, 27, 2149–2160.
  24. Watanabe, M.; Horie, H.; Kurata, Y.; Inoue, Y.; Notsu, T.; Wakimizu, T.; Adachi, M.; Yamamoto, K.; Morikawa, K.; Kuwabara, M.; et al. Esm1 and Stc1 as angiogenic factors responsible for protective actions of adipose-derived stem cell sheets on chronic heart failure after rat myocardial infarction. Circ. J. 2021, 85, 657–666.
  25. Choi, S.-C.; Seo, H.-R.; Cui, L.-H.; Song, M.-H.; Noh, J.-M.; Kim, K.-S.; Choi, J.-H.; Kim, J.-H.; Park, C.-Y.; Joo, H.J.; et al. Modeling hypoxic stress in vitro using human embryonic stem cells derived cardiomyocytes matured by fgf4 and ascorbic acid treatment. Cells 2021, 10, 2741.
  26. Ellis, B.W.; Acun, A.; Isik Can, U.; Zorlutuna, P. Human IPSC-derived myocardium-on-chip with capillary-like flow for personalized medicine. Biomicrofluidics 2017, 11, 024105.
  27. Basara, G.; Gulberk Ozcebe, S.; Ellis, B.W.; Zorlutuna, P. Tunable human myocardium derived decellularized extracellular matrix for 3d bioprinting and cardiac tissue engineering. Gels 2021, 7, 70.
  28. Ren, X.; Ellis, B.W.; Ronan, G.; Blood, S.R.; DeShetler, C.; Senapati, S.; March, K.L.; Handberg, E.; Anderson, D.; Pepine, C.; et al. A multiplexed ion-exchange membrane-based miRNA (MIX·miR) detection platform for rapid diagnosis of myocardial infarction. Lab A Chip 2021, 21, 3876–3887.
  29. Zhang, H.; Dvornikov, A.V.; Huttner, I.G.; Ma, X.; Santiago, C.F.; Fatkin, D.; Xu, X. A Langendorff-like system to quantify cardiac pump function in adult zebrafish. DMM Dis. Model. Mech. 2018, 11, dmm034819.
  30. Li, H.; Liu, C.; Bao, M.; Liu, W.; Nie, Y.; Lian, H.; Hu, S. Optimized Langendorff perfusion system for cardiomyocyte isolation in adult mouse heart. J. Cell. Mol. Med. 2020, 24, 14619–14625.
  31. Rossello, X.; Hall, A.R.; Bell, R.M.; Yellon, D.M. Characterization of the Langendorff Perfused Isolated Mouse Heart Model of Global Ischemia-Reperfusion Injury: Impact of Ischemia and Reperfusion Length on Infarct Size and LDH Release. J. Cardiovasc. Pharmacol. Ther. 2016, 21, 286–295.
  32. Lindsey, M.L.; Bolli, R.; Canty, J.M., Jr.; Du, X.-J.; Frangogiannis, N.G.; Frantz, S.; Gourdie, R.G.; Holmes, J.W.; Jones, S.P.; Kloner, R.A.; et al. Guidelines for experimental models of myocardial ischemia and infarction. Am. J. Physiol. Heart Circ. Physiol. 2018, 314, H812–H838.
  33. Alqarni, F.; Alsaadi, M.; Karem, F. MR image analysis of ex-vivo mouse model of heart ischemia. Saudi J. Biol. Sci. 2021, 28, 1990–1998.
  34. Montero-Bullon, J.F.; Aveiro, S.S.; Melo, T.; Martins-Marques, T.; Lopes, D.; Neves, B.; Girão, H.; Rosário MDomingues, M.; Domingues, P. Cardiac phospholipidome is altered during ischemia and reperfusion in an ex vivo rat model. Biochem. Biophys. Rep. 2021, 27, 101037.
  35. Haubner, B.J.; Adamowicz-Brice, M.; Khadayate, S.; Tiefenthaler, V.; Metzler, B.; Aitman, T.; Penninger, J.M. Complete cardiac regeneration in a mouse model of myocardial infarction. Aging 2012, 4, 966–977.
  36. Darehzereshki, A.; Rubin, N.; Gamba, L.; Kim, J.; Fraser, J.; Huang, Y.; Billings, J.; Mohammadzadeh, R.; Wood, J.; Warburton, D.; et al. Differential regenerative capacity of neonatal mouse hearts after cryoinjury. Dev. Biol. 2015, 399, 91–99.
  37. Mahmoud, A.I.; Porrello, E.R.; Kimura, W.; Olson, E.N.; Sadek, H.A. Surgical models for cardiac regeneration in neonatal mice. Nat. Protoc. 2014, 9, 305–311.
  38. Bei, Y.; Chen, C.; Hua, X.; Yin, M.; Meng, X.; Huang, Z.; Qi, W.; Su, Z.; Liu, C.; Lehmann, H.I.; et al. A modified apical resection model with high accuracy and reproducibility in neonatal mouse and rat hearts. Npj Regen. Med. 2023, 8, 9.
  39. Ye, L.; D’agostino, G.; Loo, S.J.; Wang, C.X.; Su, L.P.; Tan, S.H.; Tee, G.Z.; Pua, C.J.; Pena, E.M.; Cheng, R.B.; et al. Early regenerative capacity in the porcine heart. Circulation 2018, 138, 2798–2808.
  40. Garbern, J.C.; Mummery, C.L.; Lee, R.T. Model Systems for Cardiovascular Regenerative Biology. Cold Spring Harb. Perspect. Med. 2013, 3, a014019.
  41. Reddy, P.C.; Gungi, A.; Unni, M. Cellular and Molecular Mechanisms of Hydra Regeneration. In Evo-Devo: Non-Model Species in Cell and Developmental Biology; Results and Problems in Cell Differentiation; Tworzydlo, W., Bilinski, S.M., Eds.; Springer International Publishing: Cham, Germany, 2019; Volume 68, pp. 259–290. Available online: http://link.springer.com/10.1007/978-3-030-23459-1_12 (accessed on 28 July 2023).
  42. Jopling, C.; Sleep, E.; Raya, M.; Martí, M.; Raya, A.; Izpisúa Belmonte, J.C. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 2010, 464, 606–609.
  43. Chablais, F.; Veit, J.; Rainer, G.; Jaźwińska, A. The zebrafish heart regenerates after cryoinjury- induced myocardial infarction. BMC Dev. Biol. 2011, 11, 21.
  44. González-Rosa, J.M.; Martín, V.; Peralta, M.; Torres, M.; Mercader, N. Extensive scar formation and regression during heart regeneration after cryoinjury in zebrafish. Development 2011, 138, 1663–1674.
  45. Hein, S.J.; Lehmann, L.H.; Kossack, M.; Juergensen, L.; Fuchs, D.; Katus, H.A.; Hassel, D. Advanced Echocardiography in Adult Zebrafish Reveals Delayed Recovery of Heart Function after Myocardial Cryoinjury. PLoS ONE 2015, 10, e0122665.
  46. Wang, J.; Panáková, D.; Kikuchi, K.; Holdway, J.E.; Gemberling, M.; Burris, J.S.; Singh, S.P.; Dickson, A.L.; Lin, Y.-F.; Sabeh, M.K.; et al. The regenerative capacity of zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion. Development 2011, 138, 3421–3430.
  47. González, A.; Schelbert, E.B.; Díez, J.; Butler, J. Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives. J. Am. Coll. Cardiol. 2018, 71, 1696–1706.
  48. Manuel, G.-R.J.; Michka, S.; Dorothy, F.; Mark, H.S.; Loren, J.F.; Burns, C.E.; Geoffrey, C. Myocardial Polyploidization Creates a Barrier to Heart Regeneration in Zebrafish Article Myocardial Polyploidization Creates a Barrier to Heart Regeneration in Zebrafish. Dev. Cell 2018, 44, 433–446.
  49. Cano-Martínez, A.; Vargas-González, A.; Guarner-Lans, V.; Prado-Zayago, E.; León-Oleda, M.; Nieto-Lima, B. Functional and structural regeneration in the axolotl heart (Ambystoma mexicanum) after partial ventricular amputation. Arch. Cardiol. Mex. 2010, 80, 21147570.
  50. Lauridsen, H.; Pedersen, M. Circulating cells contribute to cardiac regeneration in the axolotl. FASEB J. 2015, 29, 1029.14.
  51. Jacobs, G.F.M.; Michielsen, R.P.A.; Kühn, E.R. Thyroxine and Triiodothyronine in Plasma and Thyroids of the Neotenic and Metamorphosed Axolotl Ambystoma mexicanurn: Influence of TRH Injections. Gen. Comp. Endocrinol. 1998, 70, 145–151.
  52. Monaghan, J.R.; Stier, A.C.; Michonneau, F.; Smith, M.D.; Pasch, B.; Maden, M.; Seifert, A.W. Experimentally induced metamorphosis in axolotls reduces regenerative rate and fidelity. Regeneration 2014, 1, 2–14.
  53. Rollins-Smith, L.A. Metamorphosis and the amphibian immune system. Immunol. Rev. 1998, 166, 221–230.
  54. Godwin, J.W.; Rosenthal, N. Scar-free wound healing and regeneration in amphibians: Immunological influences on regenerative success. Differentiation 2014, 87, 66–75.
  55. Hirose, K.; Payumo, A.Y.; Cutie, S.; Hoang, A.; Zhang, H.; Guyot, R.; Lunn, D.; Bigley, R.B.; Yu, H.; Wang, J.; et al. Evidence for hormonal control of heart regenerative capacity during endothermy acquisition. Science 2019, 364, 184–188.
  56. Laube, F.; Heister, M.; Scholz, C.; Borchardt, T.; Braun, T. Re-programming of newt cardiomyocytes is induced by tissue regeneration. J. Cell Sci. 2006, 119, 4719–4729.
  57. Oberpriller, J.O.; Oberpriller, J.C. Response of the adult newt ventricle to injury. J. Exp. Zool. 1974, 187, 249–253.
  58. Witman, N.; Murtuza, B.; Davis, B.; Arner, A.; Morrison, J.I. Recapitulation of developmental cardiogenesis governs the morphological and functional regeneration of adult newt hearts following injury. Dev. Biol. 2011, 354, 67–76.
  59. Piatkowski, T.; Mühlfeld, C.; Borchardt, T.; Braun, T.; Chong, J.J.; Reinecke, H.; Iwata, M.; Torok-Storb, B.; Stempien-Otero, A.; Murry, C.E.; et al. Reconstitution of the Myocardium in Regenerating Newt Hearts is Preceded by Transient Deposition of Extracellular Matrix Components. Stem Cells Dev. 2013, 22, 1921–1931.
  60. Rumyantsev, P.P. Growth and hyperplasia of cardiac muscle cells. Sov. Med. Rev. 1991. Available online: https://www.taylorfrancis.com/books/mono/10.4324/9781315076652/growth-hyperplasia-cardiac-muscle-cells-rumyantsev (accessed on 20 July 2023).
  61. Novikov, A.I.; Khloponin, P.A. O reparativnykh protsessakh v émbrional’nom i postémbrional’nom miokardiogeneze Gallus domesticus L.
  62. Porrello, E.R.; Mahmoud, A.I.; Simpson, E.; Hill, J.A.; Richardson, J.A.; Olson, E.N.; Sadek, H.A. Transient regenerative potential of the neonatal mouse heart. Science 2011, 331, 1078–1080.
  63. Gunadasa-Rohling, M.; Masters, M.; Maguire, M.L.; Smart, S.C.; Schneider, J.E.; Riley, P.R. Magnetic Resonance Imaging of the Regenerating Neonatal Mouse Heart. Circulation 2018, 138, 2439–2441.
  64. Porrello, E.R.; Mahmoud, A.I.; Simpson, E.; Johnson, B.A.; Grinsfelder, D.; Canseco, D.; Mammen, P.P.; Rothermel, B.A.; Olson, E.N.; Sadek, H.A. Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc. Natl. Acad. Sci. USA 2013, 110, 187–192.
  65. Strungs, E.G.; Ongstad, E.L.; O’Quinn, M.P.; Palatinus, J.A.; Jourdan, L.J.; Gourdie, R.G. Cryoinjury models of the adult and neonatal mouse heart for studies of scarring and regeneration. Methods Mol. Biol. 2013, 1037, 343–353.
  66. Sophy, A.J.; Michele, A.S.; Frank, K.L.; Martin, B.; Michael, H.; Shaun, R.; Jane, C.L.; Robert, M.D.; Alexander, Y.; Bernd, F.; et al. c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc. Natl. Acad. Sci. USA 2012, 109, 13380–13385.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Developmental Biology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Juan Manuel Castillo-Casas
,
Sheila Caño-Carrillo
,
Cristina Sánchez-Fernández
,
Diego Franco
,
Estefanía Lozano-Velasco
View Times: 208
Revisions: 2 times (View History)
Update Date: 13 Oct 2023
Table of Contents
    1000/1000
    Hot Most Recent
    ScholarVision Creations
    Feedback